SOL SpA
MIL:SOL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.6
37.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
SOL SpA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | IT |
Market Cap | 3.3B EUR |
Net Margin |
9%
|
Country | UK |
Market Cap | 207.9B EUR |
Net Margin |
19%
|
Country | FR |
Market Cap | 92.3B EUR |
Net Margin |
29%
|
Country | US |
Market Cap | 73.8B USD |
Net Margin |
32%
|
Country | JP |
Market Cap | 1.9T JPY |
Net Margin |
9%
|
Country | IN |
Market Cap | 554.8B INR |
Net Margin |
17%
|
Country | CN |
Market Cap | 24.4B CNY |
Net Margin |
8%
|
Country | JP |
Market Cap | 429.3B JPY |
Net Margin |
4%
|
Country | CN |
Market Cap | 16.5B CNY |
Net Margin |
20%
|
Country | CN |
Market Cap | 13.6B CNY |
Net Margin |
18%
|
Country | CN |
Market Cap | 8.9B CNY |
Net Margin |
12%
|
SOL SpA
Glance View
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on SOL SpA's most recent financial statements, the company has Net Margin of 9.2%.